Log In
BCIQ
Print this Print this
 

FX125L

  Manage Alerts
Collapse Summary General Information
Company Funxional Therapeutics Ltd.
DescriptionOral small molecule somatostatin receptor 2 (SSTR2) agonist
Molecular Target Somatostatin receptor 2 (SSTR2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard Indication Inflammation (unspecified)
Indication DetailsTreat inflammation
Regulatory Designation
PartnerBoehringer Ingelheim GmbH

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/30/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today